ENO

What ENO does

ENO is an over-the-counter antacid brand offering effervescent fruit salt products for fast relief from heartburn, acidity, sour stomach, gas, and indigestion. The brand is owned by Haleon Group of Companies (formerly GSK Consumer Healthcare, spun off as an independent listed entity in 2019) and operates as a product line within Haleon's consumer healthcare digestive health portfolio. Its core technology is an effervescent formulation containing Svarjiksara (Shudh) and Nimbukamlam (Shushkam) that neutralizes stomach acid on contact, with clinical-lab evidence cited by the brand indicating gastric pH begins rising within 6 seconds — faster than leading liquid and tablet antacids.

The product range spans multiple formats and flavors: ENO Fruit Salt in sachets, bottles, and multi-pack sixer bundles across Regular, Lemon, Cola, Orange, Ajwain, Mausambi, Jaljeera, and Nimbu Masala variants; the newer ENO 3in1 Powder featuring Jeera, Ajwain, and Kala Namak; and ENO Chewy Bites, a chewable tablet format in Tangy Lemon and Zesty Orange. Distribution is concentrated in India via pharmacy, general trade, and modern trade channels, with nascent marketing activation in South Africa through a TikTok-sponsored #EasterTreats campaign.

ENO generates revenue through one-time OTC sales of mass-market consumer healthcare SKUs priced at the lower end of the antacid category, targeting broad adult consumer demand for occasional and frequent acidity. The brand's commercial strategy combines event-driven seasonal marketing (Diwali, Ramzan, Easter, wedding season) with educational content marketing on acidity management, influencer partnerships, and social media engagement across YouTube, Facebook, Instagram, and TikTok. Brand-level revenue is not separately disclosed by parent Haleon, and no independent financial or headcount data exists for ENO as a standalone unit.

Name

ENO

Legal name

Haleon Group of Companies

Website

https://eno.co.in

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ENO is a Haleon-owned OTC antacid brand selling effervescent fruit salt powders and chewable tablets in India, providing fast relief from heartburn, acidity, and indigestion to mass-market adult consumers via pharmacy and retail channels.

Ownership category

akta.pro rank

Product category

OTC Antacid / Digestive Health

akta.pro primary industry

Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)

akta.pro secondary industry

Gastrointestinal & Digestive Health (HLAIADAD)

Keywords

• Antacid products
• Effervescent fruit salt
• Heartburn relief
• Acidity treatment
• OTC digestive health

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel

Revenue model

1. Consumer Healthcare OTC Sales: ENO generates revenue through the sale of over-the-counter antacid products (ENO Fruit Salt sachets and bottles, ENO 3in1 Powder, ENO Chewy Bites) via retail pharmacies, general trade, and modern trade channels across India and international markets.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

ENO is a consumer healthcare brand that manufactures and sells over-the-counter antacid products, including effervescent fruit salt powders (sachets, bottles, sixer packs) and chewable tablets. The products neutralize stomach acid on contact to provide fast relief from acidity, heartburn, sour stomach, and gas. ENO is distributed primarily through retail pharmacies, general trade, and modern trade channels across India and select international markets, and is owned by Haleon Group of Companies.

Differentiator

Problem solved

Functional benefit

Brands

• ENO Fruit Salt: Classic antacid powder product available in sachets and bottles, with multiple flavors including lemon, regular, orange, cola, ajwain, mausambi, jaljeera, and nimbu masala.
• ENO 3in1 Powder
• ENO Chewy Bites

Products and services

• ENO Fruit Salt (Sachet) Antacid powder in convenient pocket-sized sachets for fast relief from acidity, heartburn, sour stomach, and gas. Available in multiple flavors including Regular, Lemon, Orange, Cola, Ajwain, and 3in1 variants. Targeted at consumers seeking on-the-go, single-dose convenience.
• ENO Fruit Salt (Bottle) Antacid powder in bottle format for regular users who suffer from acidity, providing multiple doses for home use. Offers value for frequent users requiring ongoing acid neutralization relief.
• ENO Fruit Salt (Sixer Pack) Multi-pack bundle of ENO sachets for economy and convenience, targeting consumers who prefer bulk purchasing and household stocking.
• ENO 3in1 Powder Enhanced antacid powder variant containing traditional Indian spices (Jeera/Cumin, Ajwain/Carom seeds, and Kala Namak/Black Salt) formulated for triple action digestive relief. Targets consumers seeking Ayurvedic/heritage-inspired ingredients.
• ENO Chewy Bites Chewable antacid tablet format in bottle packaging, available in Tangy Lemon and Zesty Orange flavors for convenient on-the-go relief without water. Targeted at consumers seeking portable, discreet, and fast formats.

Quantifiable outcome

• Starts increasing gastric pH within 6 seconds, outperforming leading liquid and tablet antacids in lab studies

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• TikTokminorGTM or Marketing Partner · 25 March 2026ENO partnered with TikTok in South Africa for a sponsored #EasterTreats campaign, generating over 65 million impressions and a 6% increase in ad recall. The partnership leveraged TikTok's community-driven platform to position ENO during seasonal cultural moments.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Digene: Digene is one of India's most established OTC antacid brands, offering chewable tablets and gels for heartburn and acidity relief. It directly competes with ENO in the Indian digestive health OTC category across similar pharmacy and retail channels.
• Gelusil: Gelusil is a legacy OTC antacid brand widely available in Indian pharmacies, marketed for acid neutralization and gas relief. It competes head-to-head with ENO across general trade and modern trade channels in India.
• Gaviscon: Gaviscon, owned by Reckitt, is a leading global antacid brand with strong presence in India offering liquid and tablet formats for heartburn and reflux. It targets the same consumer use cases as ENO and competes on speed of relief and format variety.
• Pudin Hara: Pudin Hara is Dabur's herbal digestive product addressing acidity, gas, and indigestion in India. It targets the same consumer occasions as ENO but with an Ayurvedic/herbal positioning, making it a direct competitor in the Indian digestive wellness OTC space.
• Mucaine: Mucaine is an antacid syrup widely prescribed and sold over-the-counter in India for heartburn and gastric discomfort. It competes with ENO in the Indian antacid category through a different (liquid syrup) format, targeting similar symptoms.
• Gelusil MPS: Gelusil MPS (Magnesium Aluminium Silicate) is an antacid formulation distributed in India through pharmacy channels, directly competing with ENO for the same heartburn and acidity use cases.

Broad incumbents

• Tums: Tums is a global OTC antacid brand also owned by Haleon, offering chewable calcium carbonate tablets primarily in North America. As a sister brand within Haleon's digestive health portfolio, it shares parent-company infrastructure and competes in the same OTC antacid category as ENO in different geographies.
• Pepto-Bismol: Pepto-Bismol is a Haleon-owned OTC brand for digestive upset, nausea, and heartburn relief, primarily in the US market. It is comparable to ENO as a Haleon digestive health brand addressing similar symptoms across a different geography and slightly broader positioning.
• Rolaids: Rolaids is a US-focused OTC antacid brand offering chewable tablets for heartburn and acid indigestion. It competes in the same global antacid category as ENO but serves a different geographic market with similar functional positioning.

Regional players

• Hajmola: Hajmola is Dabur's flagship Indian digestive tablet brand positioned for after-meal consumption, addressing similar digestive discomfort occasions as ENO. While it overlaps in use case, it is positioned as a daily digestive aid rather than acute acidity relief.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/ENOIndia
• Facebookfacebook.com/ENOFastRelief
• Instagraminstagram.com/eno_india
• TikToktiktok.com/@eno_india
• Xx.com/ENOFastRelief

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ENO